Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 26, 2022

SELL
$224.73 - $338.64 $1,797 - $2,709
-8 Reduced 0.05%
15,692 $3.88 Million
Q1 2022

Apr 13, 2022

SELL
$277.25 - $366.29 $219,027 - $289,369
-790 Reduced 4.79%
15,700 $5.2 Million
Q1 2021

Apr 14, 2021

SELL
$285.92 - $355.13 $24,303 - $30,186
-85 Reduced 0.51%
16,490 $5.26 Million
Q3 2020

Oct 15, 2020

SELL
$255.22 - $317.0 $98,259 - $122,045
-385 Reduced 2.27%
16,575 $4.59 Million
Q2 2020

Jul 30, 2020

BUY
$141.4 - $257.09 $69,286 - $125,974
490 Added 2.98%
16,960 $4.1 Million
Q1 2020

Apr 15, 2020

BUY
$130.51 - $196.01 $71,127 - $106,825
545 Added 3.42%
16,470 $2.39 Million
Q4 2019

Jan 22, 2020

BUY
$159.31 - $223.54 $258,082 - $362,134
1,620 Added 11.32%
15,925 $2.72 Million
Q3 2019

Nov 05, 2019

BUY
$175.89 - $279.23 $825,803 - $1.31 Million
4,695 Added 48.86%
14,305 $2.54 Million
Q2 2019

Aug 09, 2019

BUY
$250.96 - $284.94 $2.41 Million - $2.74 Million
9,602 Added 120025.0%
9,610 $2.5 Million
Q3 2017

Oct 27, 2017

BUY
$145.39 - $168.6 $1,163 - $1,348
8
8 $1,000

Others Institutions Holding ABMD

About ABIOMED INC


  • Ticker ABMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 45,460,900
  • Description
  • Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...
More about ABMD
Track This Portfolio

Track Loring Wolcott & Coolidge Fiduciary Advisors LLP Portfolio

Follow Loring Wolcott & Coolidge Fiduciary Advisors LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Loring Wolcott & Coolidge Fiduciary Advisors LLP, based on Form 13F filings with the SEC.

News

Stay updated on Loring Wolcott & Coolidge Fiduciary Advisors LLP with notifications on news.